Trends in utilization and costs of migraine medications, 2017–2020
Abstract Objective This study examines changes in utilization and costs trends associated with migraine medications. Background Migraine attacks are a burden to many patients. There are many pharmacotherapy options available with newer migraine drug classes entering the market in the past decade. Li...
Main Authors: | Jennifer L. Nguyen, Kiraat Munshi, Samuel K. Peasah, Elizabeth C. S. Swart, Monal Kohli, Rochelle Henderson, Chester B. Good |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | The Journal of Headache and Pain |
Online Access: | https://doi.org/10.1186/s10194-022-01476-y |
Similar Items
-
Association of PCSK9 Inhibitor Initiation on Statin Adherence and Discontinuation
by: Christopher LaFratte, et al.
Published: (2023-09-01) -
Ticagrelor versus clopidogrel for recurrent myocardial infarction: An outcomes-based agreement
by: Samuel K. Peasah, et al.
Published: (2023-12-01) -
HIV Pretreatment Drug Resistance Trends in Mexico City, 2017–2020
by: Claudia García-Morales, et al.
Published: (2021-12-01) -
Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort
by: Marta Waliszewska-Prosół, et al.
Published: (2023-04-01) -
Trends in Medicare utilization and reimbursement for wound debridement procedures 2012–2017
by: Pranav Puri, et al.
Published: (2022-02-01)